查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009257

視網膜手術設備市場規模、佔有率、趨勢和預測：按設備類型、應用、最終用途和地區分類，2026-2034 年

Retinal Surgery Devices Market Size, Share, Trends and Forecast by Equipment Type, Application, End-Use, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2025年全球視網膜手術設備市場規模為23億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以6.14%的複合年成長率成長，到2034年達到41億美元。目前，北美市場主導地位，預計2025年將佔據約35%的市場。推動該市場成長的主要因素是人口老化和糖尿病盛行率上升導致糖尿病視網膜病變和老齡化黃斑部病變（AMD）等視網膜疾病的日益普遍。微創手術（例如玻璃體切除手術）的技術進步正在改善治療效果。醫療保健支出的成長、新興市場眼科醫療服務可近性的提高以及政府促進早期診斷的措施進一步推動了市場需求。此外，研發投入的增加和創新設備的推出也進一步擴大了視網膜手術設備的市場佔有率。

視網膜疾病（例如老齡化黃斑部病變(AMD)、糖尿病視網膜病變和視網膜剝離）的日益普遍是推動該市場成長的主要因素。微創手術技術的進步，例如玻璃體切除手術(MIVS)，正在提高治療效果和患者預後。此外，易患視網膜疾病的老年人口不斷增加，也進一步刺激了市場需求。預計到 2080 年，全球人口將達到 103 億的峰值，屆時 65 歲及以上人口預計將達到 22 億，超過 18 歲以下兒童人口。預期壽命也不斷延長，預計將從 2024 年的 73.3 歲成長到 2054 年的 77.4 歲，這將導致老年人對眼科醫療服務的需求增加。與老化相關的人口結構變化凸顯了投資尖端視網膜手術技術以改善全球快速成長的老年族群視覺健康的迫切需求。新興經濟體醫療保健支出不斷成長以及獲得先進眼科醫療服務的機會增加，也推動了視網膜手術設備市場的成長。政府的支持措施以及人們對早期診斷和治療重要性的認知不斷提高，也對市場擴張起到了重要作用。

美國作為重要的區域市場脫穎而出，這主要是由於慢性眼科疾病（尤其是老年族群）的盛行率不斷上升。超過1200萬40歲以上的美國成年人患有視力障礙，其中100萬人完全失明。預計到2050年，這一數字將翻倍以上，主要原因是人口老化和糖尿病等慢性疾病。視力障礙位列美國成年人十大健康問題之列，其中90%的可預防性失明是由糖尿病視網膜病變引起的。預計到2050年，視力障礙造成的經濟損失將達到3,730億美元，因此對用於治療這些不可避免的疾病的創新視網膜手術設備的需求龐大。糖尿病患者人數的增加加劇了對糖尿病視網膜病變治療的需求，而玻璃體切除系統和手術雷射技術的進步正在改善治療效果。完善的醫療保健基礎設施和主要行業參與者的存在正在推動先進技術的快速應用。此外，患者意識的提高和積極主動的篩檢計畫有助於疾病的早期發現，並提高手術治療品質。新醫療設備的監管核准和製造商之間的策略合作進一步刺激了市場擴張，並確保了尖端視網膜手術解決方案的穩定供應。

視網膜手術設備市場趨勢：

眼科疾病發生率上升

在全球範圍內，視力相關疾病的盛行率不斷上升，是推動市場成長的主要因素。黃斑部病變、視網膜色素變性和糖尿病視網膜病變等疾病的發生率日益增高，尤其是在全球糖尿病患者和老年族群。此外，光是糖尿病視網膜病變就影響了全球25.2%的糖尿病患者，其中第1型糖尿病患者的發生率（約75%）顯著高於第2型糖尿病患者（50%）。根據視網膜手術設備市場的預測，這些令人擔憂的統計數據正在推動對高效手術解決方案的需求。需要精準治療的病例數量不斷增加，推動了視網膜手術設備的應用。這些設備被認為具有成本效益高、節省時間、手術效率高等優點。隨著全球糖尿病患者數量的成長，這一趨勢預計將持續下去，從而促進市場擴張。為此，醫療專業人員正優先考慮早期診斷和先進的手術干預，以有效控制進行性眼科疾病。

人口老化和與老齡化相關的視力喪失

全球人口老化是推動視網膜手術器械市場需求的另一個重要因素。老年人更容易患上與老齡化相關的眼科疾病，例如白內障、青光眼和老花眼。白內障的高發生率就是一個明顯的例子。 45-54歲族群中，女性盛行率為4%，男性為2.4%；而75歲以上族群中，女性盛行率高達30.49%，男性為27.97%。隨著全球人口老化，醫療領域對針對老年患者特定需求的先進手術介入措施的需求也相應增加。視網膜手術器械具有顯著優勢，例如減輕疼痛、減少疤痕和縮短恢復時間，這些優勢對老年患者尤其具有吸引力。老年族群罹患慢性視力障礙的風險日益增加，促使醫療系統和醫療設備製造商投資於能夠改善治療效果並同時確保老年人舒適和安全的技術。因此，這進一步提升了視網膜手術器械的市場前景。

技術進步和糖尿病發生率上升

微創手術器械和設備的科技進步正在顯著影響視網膜手術器械市場的未來。同時，全球糖尿病患者人數的快速成長也進一步刺激了對專業眼科醫療解決方案的需求。根據國際糖尿病聯盟（IDF）統計，目前約有5.89億成年人患有糖尿病，預計到2050年這數字將達到8.53億。這種慢性疾病每年導致超過340萬人死亡，也是糖尿病視網膜病變及相關視力障礙病例不斷增加的主要原因。微創手術的興起與更廣泛的醫療需求趨勢相吻合，即提高患者療效、加快康復速度並提升安全性。視網膜手術器械的創新不僅能夠帶來這些好處，還能滿足日益成長的糖尿病患者群體的獨特醫療需求。技術創新與人口健康水準的提高，以及全球對治療方法方案認知的不斷增強，共同推動了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球視網膜手術設備市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依設備類型分類

  • 玻璃體切除裝置
  • 視網膜雷射設備
  • 手術器械
    • 主要類型
      • 套管
      • 鉗子
      • 刀具
      • 低溫探針
      • 其他

第7章 市場區隔：依應用領域分類

  • 糖尿病視網膜病變
  • 視網膜剝離
  • 其他

第8章 市場區隔：依最終用途分類

  • 醫院
  • 眼科診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章 價格指標

第14章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Alcon Management SA
    • Bausch & Lomb Incorporated
    • Carl Zeiss
    • Ellex Medical Lasers
    • Erbe Elektromedizin
    • Escalon Medicals
    • Iridex Corporation
    • Leica Microsystems GmbH
    • Lumenis
    • Nidek Co. Ltd.
    • Optos PLC
    • Second Sigh Medical Products
    • Synergetics USA Inc.
    • Topcon Corporation
Product Code: SR112026A2059

The global retinal surgery devices market size was valued at USD 2.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.1 Billion by 2034, exhibiting a CAGR of 6.14% during 2026-2034. North America currently dominates the market, holding a significant market share of around 35% in 2025. The market is driven by the rising prevalence of retinal disorders, including diabetic retinopathy and AMD, fueled by aging population and increasing diabetes cases. Technological advancements in minimally invasive surgeries, such as microincision vitrectomy, enhance treatment efficacy. Growing healthcare expenditure, improved access to eye care in emerging markets, and government initiatives promoting early diagnosis further propel demand. Additionally, increasing R&D investments and the introduction of innovative devices are further expanding the retinal surgery devices market share.

The market is driven by the rising prevalence of retinal disorders such as age-related macular degeneration (AMD), diabetic retinopathy, and retinal detachment. Technological advancements in minimally invasive surgical techniques, such as microincision vitrectomy surgery (MIVS), enhance treatment efficacy and patient outcomes. Additionally, the growing geriatric population, which is more susceptible to retinal diseases, fuels market demand. By 2080, the global number of individuals aged 65 and above is expected to stand at 2.2 billion, outnumbering children under the age of 18, against a background of a peak global population of 10.3 billion in the 2080s. Life expectancy is also increasing, rising from 73.3 years in 2024 to 77.4 years in 2054, resulting in increased demand for eye care services among the elderly population. The changing demographics of the aging population indicate the urgent need for investment in cutting-edge retinal surgery technologies to improve vision health in the fast-growing geriatric markets around the world. Increased healthcare expenditure and improved access to advanced ophthalmic care in emerging economies further contribute to the retinal surgery devices market growth. Supportive government initiatives and increasing awareness about early diagnosis and treatment also play a significant role in expanding the market.

The United States stands out as a key regional market, primarily driven by the rising incidences of chronic eye conditions, particularly among the aging population. Over 12 million U.S. adults aged 40 and older have vision impairment, including 1 million who are blind. The number is estimated to more than double by the year 2050, mostly due to aging and chronic conditions such as diabetes. Vision disability ranks among the leading ten health problems in U.S. adults, with diabetic retinopathy causing 90% of cases of preventable blindness. Since the economic cost of vision impairment is likely to hit USD 373 Billion by 2050, demand for innovative retinal surgery equipment to treat such inescapable disorders is high. Increasing cases of diabetes contribute to higher demand for diabetic retinopathy treatments, while innovations in vitrectomy systems and surgical lasers improve procedural outcomes. Strong healthcare infrastructure and the presence of major industry players drive rapid adoption of advanced technologies. Additionally, heightened patient awareness and proactive screening programs facilitate early disease detection, improving surgical interventions. Regulatory approvals for novel devices and strategic collaborations among manufacturers further stimulate market expansion, ensuring a steady pipeline of cutting-edge retinal surgical solutions.

RETINAL SURGERY DEVICES MARKET TRENDS:

Rising Eye Disorder Prevalence

The increasing global prevalence of vision-related disorders among the masses is a major catalyst for growth in the market. Conditions such as macular degeneration, retinitis pigmentosa, and diabetic retinopathy are becoming more widespread, especially among diabetic and aging populations across the globe. Along with this, diabetic retinopathy alone affects 25.2% of individuals living with diabetes worldwide, with a significantly higher occurrence in type 1 diabetics (approximately 75%) compared to 50% in type 2 diabetics. According to the retinal surgery devices market forecast, these alarming statistics are pushing the demand for effective and efficient surgical solutions. The rise in cases requiring precise treatment is leading to increased adoption of retinal surgery devices, which are considered cost-effective, time-saving, and highly efficient during procedures. With a growing global diabetic population, this trend is expected to persist, supporting market expansion. In response, healthcare providers are prioritizing early diagnosis and advanced surgical interventions to manage progressive eye diseases effectively.

Geriatric Population and Age-Related Vision Loss

The aging demographic worldwide is another prominent factor enhancing the retinal surgery devices market demand. Elderly individuals are more susceptible to age-related ocular diseases such as cataracts, glaucoma, and presbyopia. Cataract prevalence provides a clear example: among individuals aged 45-54, the condition affects 4% of females and 2.4% of males, which dramatically increases to 30.49% in females and 27.97% in males aged 75 and above. As the global population continues to age, the healthcare sector is experiencing a corresponding rise in the need for advanced surgical interventions tailored to the unique requirements of older patients. Retinal surgery devices offer significant benefits, including less pain, minimal scarring, and quicker recovery times, which are particularly appealing for geriatric patients. This demography's growing vulnerability to chronic vision issues is encouraging healthcare systems and device manufacturers to invest in technologies that improve outcomes while ensuring comfort and safety for older individuals. Therefore, this is further creating a positive retinal surgery devices market outlook.

Technological Advancements and Rising Diabetes Incidence

Technological progress in minimally invasive surgical tools and equipment is significantly shaping the future of the retinal surgery devices market. Simultaneously, the steep rise in global diabetes cases is creating further demand for specialized eye care solutions. According to the International Diabetes Federation (IDF), nearly 589 million adults currently live with diabetes, a number projected to rise to 853 million by 2050. This chronic condition contributes to more than 3.4 million deaths each year and is a key driver behind the increasing cases of diabetic retinopathy and related vision issues. The shift towards minimally invasive surgeries aligns with the broader push for better patient outcomes, faster recovery, and enhanced safety. Innovations in retinal surgery devices are offering these benefits while catering to the growing diabetic population's unique medical needs. As awareness of treatment options spreads globally, this convergence of technological innovation and health demographics is propelling market growth.

RETINAL SURGERY DEVICES INDUSTRY SEGMENTATION:

Analysis by Equipment Type:

  • Vitrectomy Machines
  • Retinal Laser Equipment
  • Surgical Instruments
    • Cannulas
    • Forceps
    • Cutters
    • Cryoprobes
    • Others

Vitrectomy machines stand as the largest component in 2025, holding around 44.8% of the market, driven by their critical role in treating complex retinal conditions, such as diabetic retinopathy, retinal detachment, and macular holes. These advanced systems enable precise removal of vitreous gel and scar tissue while minimizing trauma to surrounding structures, improving surgical outcomes. According to the retinal surgery devices market research report, the shift toward minimally invasive vitrectomy surgery (MIVS) with smaller-gauge instruments has further increased adoption, reducing recovery times and complications. Technological advancements, including high-speed cutters, integrated fluidics, and enhanced visualization systems, enhance surgical efficiency and safety. Additionally, the rising prevalence of retinal diseases, an aging population, and increasing diabetic cases contribute to sustained demand. Leading manufacturers continue to innovate, introducing portable and user-friendly systems that expand accessibility in both hospitals and ambulatory surgical centers. With superior efficacy and expanding applications, vitrectomy machines remain indispensable in retinal surgery, securing their position as the leading equipment type in the market.

Analysis by Application:

  • Diabetic Retinopathy
  • Retinal Detachment

Diabetic retinopathy leads the market with around 40.6% of market share in 2025, primarily due to the escalating global prevalence of diabetes and its associated ocular complications. As a leading cause of vision loss among working-age adults, this progressive condition demands advanced surgical interventions such as vitrectomy and laser photocoagulation to manage vitreous hemorrhages, retinal detachment, and macular edema. The growing diabetic population, coupled with poor glycemic control in many patients, fuels the need for early and aggressive treatment, driving demand for specialized retinal surgery devices. Additionally, increasing awareness about diabetes-related eye complications and improved screening programs have led to earlier diagnosis, expanding the patient pool requiring surgical care. Technological advancements in imaging and microsurgical tools further enhance treatment precision, supporting segment growth. With diabetes rates continuing to rise worldwide, particularly in aging populations, diabetic retinopathy is expected to maintain its dominance as the key application driving the retinal surgery devices market.

Analysis by End-Use :

  • Hospitals
  • Ophthalmology Clinics

Hospitals lead the market with around 60.1% of market share in 2025, due to their advanced infrastructure, availability of skilled ophthalmologists, and ability to handle complex retinal procedures. Equipped with state-of-the-art operating rooms and diagnostic tools, hospitals are the primary settings for vitrectomies, retinal detachment repairs, and other intricate eye surgeries. The increasing prevalence of retinal disorders, coupled with rising hospital admissions for vision-related conditions, further drives demand in this segment. Additionally, hospitals often serve as referral centers for specialized ophthalmic care, attracting patients requiring advanced surgical interventions. The growing adoption of minimally invasive retinal surgeries in hospital settings, supported by favorable reimbursement policies, also contributes to segment dominance. With continuous investments in healthcare infrastructure and the integration of cutting-edge surgical technologies, hospitals remain the preferred choice for retinal treatments, reinforcing their position as the leading end-use segment in the market.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 35%, driven by advanced healthcare infrastructure, high adoption of innovative surgical technologies, and a significant patient pool suffering from retinal disorders. The region's leadership is reinforced by the rising prevalence of diabetes and age-related macular degeneration (AMD), increasing demand for vitrectomy and other retinal procedures. Well-established reimbursement policies, particularly in the U.S., enhance patient access to advanced treatments, while strong R&D investments by key industry players accelerate product development. Additionally, the presence of leading ophthalmic centers and skilled surgeons supports the adoption of cutting-edge devices. High awareness about retinal health and proactive screening programs further contribute to early diagnosis and surgical intervention. With continuous technological advancements and favorable regulatory frameworks, North America remains the largest and most influential regional segment in the global retinal surgery devices market.

KEY REGIONAL TAKEAWAYS:

UNITED STATES RETINAL SURGERY DEVICES MARKET ANALYSIS

In 2025, the US accounted for around 85.80% of the total North America retinal surgery devices market. The United States market is primarily driven by the increasing prevalence of retinal disorders, including age-related macular degeneration (AMD) and diabetic retinopathy. According to the CDC, in 2021, approximately 9.6 million individuals in the United States were affected by diabetic retinopathy (DR). Among them, 1.84 million were experiencing vision-threatening forms of DR. In line with this, continual advancements in retinal imaging and diagnostic technologies, enabling earlier detection and more accurate treatment of retinal conditions, are propelling market growth. Furthermore, the rising aging population, which is more susceptible to retinal diseases, is contributing to market demand. Additionally, the growing adoption of minimally invasive procedures, with these techniques offering quicker recovery times and reduced risks, is driving the market expansion. The enhanced surgical outcomes facilitated by innovations in retinal surgery devices, such as improved lasers and surgical microscopes, are stimulating market appeal. Similarly, the increased awareness of retinal diseases and advancements in personalized medicine are expanding the market scope. Moreover, favorable reimbursement policies and government initiatives promoting eye health are creating lucrative opportunities in the market.

EUROPE RETINAL SURGERY DEVICES MARKET ANALYSIS

The market in Europe is experiencing growth due to increasing geriatric population leading to a higher prevalence of age-related macular degeneration and diabetic retinopathy. As per an industry report, in Europe, age-related macular degeneration (AMD) affects about 67 million individuals, projected to reach 77 million by 2050. Prevalence rises from 5% in ages 55-64 to 17.4% in those over 85, with 1.4 late-stage AMD cases per 1,000 individuals aged 60+, annually. Similarly, enhanced reimbursement policies in key European countries are making retinal procedures more accessible in the market. The growing adoption of minimally invasive vitreoretinal surgery techniques fueling the need for precision instruments, is fostering market expansion. Furthermore, continuous innovation by European manufacturers in micro-incision and illumination technologies is accelerating higher product uptake. The rising awareness campaigns and proactive screening initiatives improving early diagnosis rates are enhancing market appeal. Additionally, the expansion of ophthalmology training programs contributing to a skilled workforce, enabling the safe use of complex devices, is bolstering market development. Besides this, numerous cross-border healthcare collaborations and harmonized regulatory frameworks within the EU encouraging product approvals and regional distribution, are providing an impetus to the market.

ASIA PACIFIC RETINAL SURGERY DEVICES MARKET ANALYSIS

The Asia Pacific market is being propelled by the changing lifestyles, rising diabetes rates, and increasing diabetic retinopathy cases. According to NCBI, the number of individuals with diabetes in India rose sharply from 33 million in 2000 to 72 million in 2021 and is expected to reach 125 million by 2045. In accordance with this, rising investments in public and private healthcare infrastructure, improving access to advanced ophthalmic procedures, are supporting market expansion. The increasing presence of a large patient pool and rising disposable incomes is increasing the affordability and demand in the market. Furthermore, the expansion of medical tourism across Southeast Asia, heightening the requirement for cutting-edge retinal surgical technologies, is a significant market driver. Additionally, the growing presence of device makers in the region, augmenting access to innovative retinal surgery tools suited to local needs, is impelling the market. Moreover, favorable government-led health initiatives in countries including India and China, promoting eye health awareness and early detection, are impacting the market dynamics.

LATIN AMERICA RETINAL SURGERY DEVICES MARKET ANALYSIS

In Latin America, the market is advancing due to increasing rates of chronic eye conditions such as retinal detachment and macular holes, particularly in aging populations. Furthermore, various government-led efforts to expand universal healthcare coverage are enhancing access to ophthalmic surgeries in the market. As per NCBI, 14.14% of the population in Latin America suffers from moderate to severe vision impairment and blindness. Blindness is most prevalent in Tropical Latin America at 3.89%, and least in Southern Latin America at 0.96%. The rising awareness about preventable blindness fostering early diagnosis and timely interventions, is propelling the market growth. In addition to this, numerous regional partnerships with global manufacturers are driving advanced surgical tech and training adoption, augmenting outcomes in public and private care.

MIDDLE EAST AND AFRICA RETINAL SURGERY DEVICES MARKET ANALYSIS

The market in the Middle East and Africa is significantly progressing attributed to the growing burden of inherited retinal disorders. Similarly, increasing penetration of vision care services in underserved rural areas, expanding the treatment base, is impelling development in the market. Furthermore, the rising prevalence of hypertension and lifestyle-related conditions is leading to a rise in retinal vascular complications is driving the need for precision retinal surgery tools and advanced diagnostic equipment, thereby expanding market reach. According to NCBI, hypertension affects approximately 36% of the general population in the African region. Apart from this, strategic collaborations with international ophthalmic organizations, enhancing clinical training and knowledge transfer, are influencing the market dynamics.

COMPETITIVE LANDSCAPE:

The competitive landscape of the market is characterized by intense rivalry among key players striving to strengthen their market position. Companies are focusing on technological advancements, launching next-generation devices with enhanced precision, efficiency, and minimally invasive capabilities. Strategic collaborations, mergers, and acquisitions are common as firms aim to expand their product portfolios and geographic reach. Investments in research and development are prioritized to introduce innovative solutions for complex retinal conditions. Additionally, players are emphasizing regulatory approvals and clinical validations to ensure product efficacy and safety. Marketing strategies include educational initiatives to raise awareness among healthcare professionals, while competitive pricing and after-sales support further drive adoption. The market also sees a growing emphasis on portable and user-friendly systems to cater to diverse clinical settings, reinforcing competition.

The report provides a comprehensive analysis of the competitive landscape in the retinal surgery devices market with detailed profiles of all major companies, including:

  • Alcon Management S. A.
  • Bausch & Lomb Incorporated
  • Carl Zeiss
  • Ellex Medical Lasers
  • Erbe Elektromedizin
  • Escalon Medicals
  • Iridex Corporation
  • Leica Microsystems GmbH
  • Lumenis
  • Nidek Co. Ltd.
  • Optos PLC
  • Second Sigh Medical Products
  • Synergetics USA Inc.
  • Topcon Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the retinal surgery devices market?

2. What is the future outlook of the retinal surgery devices market?

3. What are the key factors driving the retinal surgery devices market?

4. Which region accounts for the largest retinal surgery devices market share?

5. Which are the leading companies in the global retinal surgery devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Retinal Surgery Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Equipment Type

  • 6.1 Vitrectomy Machines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Retinal Laser Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Surgical Instruments
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Cannulas
      • 6.3.2.2 Forceps
      • 6.3.2.3 Cutters
      • 6.3.2.4 Cryoprobes
      • 6.3.2.5 Others
    • 6.3.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Diabetic Retinopathy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retinal Detachment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ophthalmology Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Alcon Management S. A.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bausch & Lomb Incorporated
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Carl Zeiss
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Ellex Medical Lasers
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Erbe Elektromedizin
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Escalon Medicals
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Iridex Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Leica Microsystems GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Lumenis
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Nidek Co. Ltd.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 SWOT Analysis
    • 14.3.11 Optos PLC
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Second Sigh Medical Products
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
    • 14.3.13 Synergetics USA Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
    • 14.3.14 Topcon Corporation
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials

List of Figures

  • Figure 1: Global: Retinal Surgery Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Retinal Surgery Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Retinal Surgery Devices Market: Breakup by Equipment Type (in %), 2025
  • Figure 4: Global: Retinal Surgery Devices Market: Breakup by Application (in %), 2025
  • Figure 5: Global: Retinal Surgery Devices Market: Breakup by End-Use (in %), 2025
  • Figure 6: Global: Retinal Surgery Devices Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Retinal Surgery Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Retinal Surgery Devices (Vitrectomy Machines) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Retinal Surgery Devices (Vitrectomy Machines) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Retinal Surgery Devices (Retinal Laser Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Retinal Surgery Devices (Surgical Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Retinal Surgery Devices (Surgical Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Retinal Surgery Devices (Diabetic Retinopathy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Retinal Surgery Devices (Retinal Detachment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Retinal Surgery Devices (Retinal Detachment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Retinal Surgery Devices (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Retinal Surgery Devices (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Retinal Surgery Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Retinal Surgery Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Retinal Surgery Devices (Ophthalmology Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Retinal Surgery Devices (Others) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Retinal Surgery Devices (Others) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia Pacific: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia Pacific: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Retinal Surgery Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Retinal Surgery Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Global: Retinal Surgery Devices Industry: SWOT Analysis
  • Figure 75: Global: Retinal Surgery Devices Industry: Value Chain Analysis
  • Figure 76: Global: Retinal Surgery Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Retinal Surgery Devices Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Retinal Surgery Devices Market Forecast: Breakup by Equipment Type (in Million USD), 2026-2034
  • Table 3: Global: Retinal Surgery Devices Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Retinal Surgery Devices Market Forecast: Breakup by End-Use (in Million USD), 2026-2034
  • Table 5: Global: Retinal Surgery Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Retinal Surgery Devices Market: Competitive Structure
  • Table 7: Global: Retinal Surgery Devices Market: Key Players